IL2 and neoplasm: Importantly, the capacity of priming and IL-2 stimulation to trigger cytotoxicity was patient-dependent and mutually exclusive, in that NK cells from ~50% of patients preferentially responded to tumor priming, whereas NK cells from the remaining patients preferentially responded to IL-2 stimulation.